Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study

• Main Authors: Yuuki Akagi (Author), Akiko Iketaki (Author), Haruna Kimura (Author), Yuki Matsudaira (Author), Takami Yoshida (Author), Takahiro Nishimura (Author), Yohei Kawano (Author), Yasunari Mano (Author), Erina Shigematsu (Author), Makoto Ujihara (Author)
• Format: Book
• Published: BMC, 2020-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Repaglinide is widely prescribed to reduce postprandial hyperglycemia and elevated glycated hemoglobin (HbA1c) levels associated with type 2 diabetes, and clopidogrel is a thienopyridine antiplatelet agent and widely used in cardiovascular and cerebrovascular diseases. It has bee...